$1846.00—Stale · unknown old
TLV • Last print unknown ago
$1846.00—Stale · unknown old
9/28/26
Pulsenmore (PULS.TA)
Monday
9:05 AM
ThesisRecent competitive pressures and negative cash flow trends are raising concerns among investors about the company's growth trajectory.
Revenue Outlook
What Moves the Stock
- 01Regulatory approvals for new devices
- 02Partnerships with healthcare providers
- 03Market adoption rates in target geographies
- 04Technological advancements in remote monitoring
- 05Sales of remote monitoring devices - 100%
- 06Growth in telehealth and remote patient monitoring
- 07Increased focus on maternal health solutions
FY2024 Snapshot
- Revenue
- $10M
- Rev. Growth
- +56.1%
- Gross Margin
- 37.0%
- Op. Margin
- -437%
- Net Margin
- -380%
- Net Income
- $-37M
- NI Growth
- +37.3%
- EPS
- $-5.76
- 1Y Return
- -46.6%
PULS.TA Chart
My Notes
- "Investors are increasingly cautious as competition heats up in the remote monitoring space."
- Moat: The company's proprietary technology provides a moderate level of competitive advantage…
- growth - Investors are likely attracted to the potential for rapid revenue growth in the healthcare technology sector.
- Low interest rates can facilitate access to financing for expansion, while rising rates may increase the cost of capital…
- Watch on earnings: Regulatory approval timelines for new devices, Market penetration rates in Europe and Asia, Gross margin trends.
One Sentence Summary:
Pulsenmore: the story is balanced — regulatory approvals for new devices.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
Explore More
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers